What is King Pharmaceuticals's international — year 1?

King Pharmaceuticals (KG) reported international — year 1 of 41.8% in Q4 2025.

What does international — year 1 mean?

This metric represents the first year of the loss development cycle for the international segment, capturing claims activity and payments shortly after policy inception. It is used to analyze the speed of claim reporting and the initial loss emergence patterns for the most recent underwriting year. This data point is critical for early-stage performance monitoring and identifying emerging loss trends.

King Pharmaceuticals KG International — Year 1

Other product segments

All other lines

57%—

Commercial Auto Liability

11.9%—

General Liability

5.9%—

European Hospital Liability

3.2%—

Similar metrics at other companies

CNAInternational — Year 1

15%—

AXSInsurance — Year 1

29.5%—

GLREFinancial — Year 1

28%-12.6pp

CNAInternational — Year 2

22.6%—

UFCSPersonal — Year 1

51.3%-3.8pp

GLREHealth — Year 1

114.6%0.0pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's international — year 1.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's international — year 1?: King Pharmaceuticals (KG) reported international — year 1 of 41.8% in Q4 2025.
What does international — year 1 mean?: This metric represents the first year of the loss development cycle for the international segment, capturing claims activity and payments shortly after policy inception. It is used to analyze the speed of claim reporting and the initial loss emergence patterns for the most recent underwriting year. This data point is critical for early-stage performance monitoring and identifying emerging loss trends.